The campaign “CODE: Prevention – Now is the time to have time“ will be held today at 12:00 in Central Halls, Sofia. This month's edition is dedicated to diabetes and neuroendocrine tumors, and guests will receive a free screening and voucher for a free test.
During the event, attendees will hear valuable information from proven medical specialists in the relevant field. Prof. Dr. Tsvetalina Tankova, head of the Diabetology Clinic at the University Specialized Hospital of Endocrinology “Acad. Ivan Penchev“, Sofia – the only specialized clinic for diabetes mellitus in the country, will tell the most important things about diabetes as a disease. Head of the Department of Endocrinology, MF, Medical University-Sofia, and specialist in Internal Medicine and Endocrinology and Metabolic Diseases, Prof. Dr. Tankova has over 500 participations in national and international scientific events and is a member of numerous international organizations. Among her greatest accomplishments is authoring the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) global guidelines for the treatment of type 2 diabetes mellitus published in 2022.
Dr. Vera Megdanova-Chipeva from the Medical Oncology Clinic of the Medical Oncology Hospital “Tsarica Joanna - ISUL“ will address the topic of rare neuroendocrine tumors called neuroendocrine neoplasms (NENs). On a global scale, these diseases are a challenge for diagnosis and treatment, and Dr. Megdanova is one of the few doctors in Bulgaria profiled in this field. She has a focused interest in the treatment of GIT, NEN, sarcoma and GIST tumors. He has conducted numerous trainings over the years in these areas in a number of centers in Europe.
The guests of the event will be provided with a contact for a free examination with specialists “Endocrinology and metabolic diseases“ in DKC XVII-Sofia. Attendees will also receive vouchers for a free test: Glycated Hemoglobin, from Medical Laboratories Sinevo Bulgaria. This test is a valuable indicator for the diagnosis and follow-up of diabetes, reflecting the average blood sugar levels for the last 2-3 months. It is recommended for early detection of prediabetic conditions and is a reliable method of diagnosis.